YHLO News
中文版 English
News
News > YHLO News
Contribution to Wuhan with SARS-CoV-2 IgG/IgM Assays
      Date:2020-03-01

On 25 February, 2020, YHLO delivered a total of 100,000 tests of SARS-CoV-2 IgG/IgM CLIA assays to some Wuhan hospitals, including the famous Huoshenshan Hospital, Fangcang Hospital, Tongji Medical College of Huazhong University of Science and Technology, Hubei General Hospital, District General Hospital of the People's Liberation Army and the other 8 famous medical institutions in Hubei. This is the 6th time that YHLO donated diagnostic kits, instruments and medical protective devices to Hubei Province. 



This is the first time that YHLO direct supplies diagnostic products for new SARS-CoV-2 detection to Huoshenshan Hospital, which is very famous because it was constructed within 10 days (starting from 23 January 2019) in response to the outbreak of COVID-19 (Coronavirus Disease-19) outbreak, bearing the great expectations of successful fighting against noval coronavirus. There are 1,400 medical specialists from People’s Liberation Army in Huoshenshan Hospital, which covers an area of 60,000 m2 with 1,000 beds. This hospital is responsible for diagnosis and treatment of patients with severe SARS-CoV-2 infection in Wuhan. YHLO is a company with strong social responsibility, and we want to fight against SARS-CoV-2 infection together with all Chinese hospitals, especially front-line hospitals like Huoshenshan Hospital. 



Based on initial clinical evaluation data from Huoshenshan Hospital, YHLO reagents demonstrated excellent performance for detection of SARS-CoV-2 IgG/IgM, the sensitivity and specificity for IgM are 88.2% and 99.0% respectively, and the sensitivity and specificity for IgM IgG are 97.8% and 97.9%. Antibody testing is a valuable supplementary tool for RT-PCR, and it is especially useful for patients with negative RT-PCR results. 




Since the outbreak of the disease, YHLO has supplied many batches of medical products to the first-line hospitals, and we are convinced that the final victory against COVID-19 will come soon. 

CopyRight@2019 Shenzhen YHLO Biotech Co., Ltd. rights reserved
Headquarter: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
Int'l Business Office: Rm.501, Building A1, Kexing Science Park, No.15 Keyuan Road, Nanshan District, 518057 Shenzhen, P.R.China
Tel: +86 755 26601910   /   Fax: +86 755 26473319   /   Email: marketing@szyhlo.com

About YHLONewsProductsServicesJoin UsInvestor RelationsContact Us